pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·May 5·1 min read
save

Supreme Court temporarily restores broad access to abortion pill mifepristone

May 5, 2026·read at STAT ↗RegulatoryNeutral

The Supreme Court issued an order on Monday that temporarily reinstates wide availability of the abortion medication mifepristone. The order follows a federal appeals court decision that had threatened pharmacy and mail access to the drug. The court’s directive will stay in effect until the end of the next day, giving both sides time to respond while the case proceeds.

The temporary measure is seen as significant for biotech and pharmaceutical leaders, regardless of their stance on the issue, because it affects distribution channels for a widely used medication.

The newsletter also includes a brief overview of hantavirus, reminding readers not to panic while providing basic health information alongside other recent health news.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “What you need to know about hantavirus (don’t panic)”

read at STAT ↗
996 words · retrieved May 5
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
JOHNSON & JOHNSONMAIA Biotechnology, Inc.RISING
drugs
MIFEPRISTONE3hepatitis B vaccine
topics
Psychiatry & CNS3IBD (Crohn's + UC)Infectious DiseaseOphthalmologyVaccine

related stories

  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • May 15Mail-order abortion pills are legal (for now)STAT
  • Apr 27Opinion: I’m a fourth-year med student, but I only learned one historical example of medical racismSTAT
  • Dec 22Fierce Biotech Fundraising Tracker '26: KymaThera corrals $80M; RougeTx lifts off with $58MFierce Biotech
  • 2h agoAdecto, Aviceda shut downBioSpace